ImmunityBio, NantKwest Announce First Patient Dosed in Phase 1 Clinical Trial of Second-Generation COVID-19 Vaccine Candidate Delivering Both Spike and Nucleocapsid of SARS-CoV-2
First patient receives ImmunityBio’s second-generation hAd5 COVID vaccine, delivering both outer S (spike) protein and…
Understanding AI’s Beneficiaries
Company Profile: Assimilate Inc.
Everyone Follows Social Media … Everyone!
The E-WIN 2.0 Edition RGB Gaming Desk
Assimilate’s Live FX 9.6 Delivers Game-changing Image-based Lighting and Projection Mapping for LED Wall-based Virtual Production Workflows